Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Saypha Volume Lidocaine is a dermal filler used for facial augmentation and the correction of deep wrinkles, folds, and facial volume loss. It combines **hyaluronic acid**—a highly elastic, cross-linked biopolymer for volumization—with **lidocaine** (0.3%) for local anesthetic effect. This formulation employs S.M.A.R.T. technology for enhanced safety, efficacy, and durability, providing natural-looking and long-lasting results. The filler is indicated for use in restoring facial volume (cheeks, chin, jawline), reducing severe facial wrinkles (nasolabial folds, marionette lines), and general facial contouring. The product is primarily injected deep subcutaneously or supraperiosteally and is administered by trained healthcare professionals. Its typical effect duration is 8–12 months.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on saypha volume lidocaine.